CBC-X Hematology Control - ARCSA Registration 30baa51ef0e2f3a0d4b04a284c2c276f
Access comprehensive regulatory information for CBC-X Hematology Control in the Ecuador medical device market through Pure Global AI's free database. This I medical device is registered under ARCSA ID 30baa51ef0e2f3a0d4b04a284c2c276f and manufactured by R&D SYSTEMS, INC. The device was registered on March 18, 2022.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.
Free Database
Powered by Pure Global AI
ARCSA Official Data
I
30baa51ef0e2f3a0d4b04a284c2c276f
CBC-X Hematology Control
ARCSA ID: 30baa51ef0e2f3a0d4b04a284c2c276f
Device Classification
Risk Class
I
Product Type
In Vitro Diagnostic
Brand Name
R&D
Commercial Name
17-062 IVD Reagents/Kits, Hematology, Control
Registration Information
Analysis ID
30baa51ef0e2f3a0d4b04a284c2c276f
Registration Date
March 18, 2022
Expiration Date
March 18, 2027
Product Use
HEMATOLOGY CONTROL
Manufacturer
Name
R&D SYSTEMS, INCCity
MINNEAPOLIS
Country
UNITED STATES
Address
614 MCKINLEY PL., N.E. MINNEAPOKIS, MN USA 55413
Product Owner
Name
R&D SYSTEMS, INC
Country
UNITED STATES
Authorized Representative